Osaka, Japan

Kenji Morimoto


 

 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 425(Granted Patents)


Location History:

  • Ibaraki, JP (1995 - 1998)
  • Matsubara, JP (2003)
  • Saijo, JP (2004 - 2006)
  • Neyagawa, JP (1998 - 2010)
  • Ehime, JP (2011)
  • Toyonaka, JP (2015 - 2016)
  • Osaka, JP (1997 - 2017)
  • Toyonaka-shi, Osaka-fu, JP (2018)

Company Filing History:


Years Active: 1995-2018

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: Kenji Morimoto: Pioneering Innovator in Pharmaceutical Chemistry

Introduction

Kenji Morimoto is a distinguished inventor based in Osaka, Japan, with an impressive portfolio of 28 patents. His contributions to pharmaceutical chemistry have significantly advanced the development of antiviral medications and morphinan derivatives used in various medical applications.

Latest Patents

Among his latest innovations are the "Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same," which presents stable crystalline forms of a compound that are invaluable in preparing medicines. Additionally, Morimoto has developed a "Substituted polycyclic carbamolypyridone derivative" that showcases antiviral activity, particularly against the influenza virus, by providing substituted 3-hydroxy-4-pyridone derivatives that inhibit cap-dependent endonuclease activity.

Career Highlights

Throughout his career, Kenji Morimoto has made significant strides in the pharmaceutical industry, particularly through his roles in companies like Sansha Electric Manufacturing Company Limited and Shionogi & Company Limited. His work in these organizations has been instrumental in driving innovations in drug development and enhancing treatment options for viral infections.

Collaborations

Morimoto has collaborated with notable figures in the field, including Toshikazu Fujiyoshi and Hajime Katsushima. These partnerships have fostered a dynamic exchange of ideas and expertise, contributing to the successful development of innovative pharmaceutical solutions.

Conclusion

Kenji Morimoto's ongoing contributions to the field of pharmaceutical chemistry underscore his role as a key innovator. With his noteworthy patents and collaborations, he continues to impact the medical landscape positively, paving the way for future advancements in drug development and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…